2019
DOI: 10.1097/qco.0000000000000570
|View full text |Cite
|
Sign up to set email alerts
|

A One Health approach to prevention, treatment, and control of campylobacteriosis

Abstract: Purpose of review To review recent findings regarding the control and treatment of campylobacteriosis. Recent findings The application of improved diagnostics has led to an upward shift in the attributable burden of Campylobacter infections, in both the United States and Europe as well as in resource-poor settings. Increased focus has brought a fundamental feature of campylobacteriosis -- the ability to cause relapsing disease back into focus, and expan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 113 publications
0
11
0
Order By: Relevance
“…Quinolone-resistant Campylobacter has been described worldwide at alarming rates. As a consequence, macrolides are presently recommended as the first-line therapy of human campylobacteriosis [41,42]. Several studies have reported high rates of quinolone resistance among Campylobacter isolated from retail food samples [5,43,44].…”
Section: Discussionmentioning
confidence: 99%
“…Quinolone-resistant Campylobacter has been described worldwide at alarming rates. As a consequence, macrolides are presently recommended as the first-line therapy of human campylobacteriosis [41,42]. Several studies have reported high rates of quinolone resistance among Campylobacter isolated from retail food samples [5,43,44].…”
Section: Discussionmentioning
confidence: 99%
“…The antibiotics commonly used to treat Campylobacter infection include macrolides, fluoroquinolones, aminoglycosides, tetracyclines, and beta-lactams [8][9][10]. Less than 1% of C. jejuni and 10% of C. coli are resistant to macrolides, which are the first-line treatment [11].…”
Section: Discussionmentioning
confidence: 99%
“…Less than 1% of C. jejuni and 10% of C. coli are resistant to macrolides, which are the first-line treatment [11]. Fluoroquinolones can also be a treatment option; however, resistance to these is increasing, which limits their effectiveness (almost 50% of C. jejuni and 60% of C. coli, with studies reporting up to 90% resistance in humans) [9,11]. In cases of strains resistant to quinolones and macrolides, or disease progression, amoxicillin with clavulanic acid or carbapenems should be used, depending on the severity of the case [9,11].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Bacteria Campylobacter spp. colonize the digestive tract of chickens during their first two weeks of life, and without causing any symptoms are released into the environment in large quantities with feces until slaughter (Schiaffino et al, 2019). In European countries, campylobacteriosis is the most common cause of infectious gastroenteritis.…”
Section: Campylobacteriosis (Campylobacter Spp)mentioning
confidence: 99%